Special Materials and Related Equipment
Human and animal pathogens and "toxins", as follows:
1C351.aViruses, whether natural, enhanced or modified, either in the form of "isolated live cultures" or as material including living material which has been deliberately inoculated or contaminated with such cultures, as follows:
1C351.a.1African horse sickness virus;
1C351.a.2African swine fever virus;
1C351.a.3Andes virus;
1C351.a.4Avian influenza virus, which are:
1C351.a.4.aUncharacterised; or
1C351.a.4.bDefined in Annex I(2) EC Directive 2005/94/EC (OJ L 10, 14.1.2006 p. 16) as having high pathogenicity, as follows:
1C351.a.4.b.1Type A viruses with an IVPI (intravenous pathogenicity index) in 6 week old chickens of greater than 1,2; or
1C351.a.4.b.2Type A viruses of the subtypes H5 or H7 with genome sequences codified for multiple basic amino acids at the cleavage site of the haemagglutinin molecule similar to that observed for other HPAI viruses, indicating that the haemagglutinin molecule can be cleaved by a host ubiquitous protease;
1C351.a.5Bluetongue virus;
1C351.a.6Chapare virus;
1C351.a.7Chikungunya virus;
1C351.a.8Choclo virus;
1C351.a.9Crimean-Congo hemorrhagic fever virus;
1C351.a.10Not used;
1C351.a.11Dobrava-Belgrade virus;
1C351.a.12Eastern equine encephalitis virus;
1C351.a.13Ebolavirus: all members of the Ebolavirus genus;
1C351.a.14Foot-and-mouth disease virus;
1C351.a.15Goatpox virus;
1C351.a.16Guanarito virus;
1C351.a.17Hantaan virus;
1C351.a.18Hendra virus (Equine morbillivirus);
1C351.a.19Suid herpesvirus 1 (Pseudorabies virus; Aujeszky`s disease);
1C351.a.20Classical swine fever virus (Hog cholera virus);
1C351.a.21Japanese encephalitis virus;
1C351.a.22Junin virus;
1C351.a.23Kyasanur Forest disease virus;
1C351.a.24Laguna Negra virus;
1C351.a.25Lassa virus;
1C351.a.26Louping ill virus;
1C351.a.27Lujo virus;
1C351.a.28Lumpy skin disease virus;
1C351.a.29Lymphocytic choriomeningitis virus;
1C351.a.30Machupo virus;
1C351.a.31Marburgvirus: all members of the Marburgvirus genus;
1C351.a.32Monkeypox virus;
1C351.a.33Murray Valley encephalitis virus;
1C351.a.34Newcastle disease virus;
1C351.a.35Nipah virus;
1C351.a.36Omsk hemorrhagic fever virus;
1C351.a.37Oropouche virus;
1C351.a.38Peste-des-petits-ruminants virus;
1C351.a.39Swine vesicular disease virus;
1C351.a.40Powassan virus;
1C351.a.41Rabies virus and all other members of the Lyssavirus genus;
1C351.a.42Rift Valley fever virus;
1C351.a.43Rinderpest virus;
1C351.a.44Rocio virus;
1C351.a.45Sabia virus;
1C351.a.46Seoul virus;
1C351.a.47Sheeppox virus;
1C351.a.48Sin Nombre virus;
1C351.a.49St. Louis encephalitis virus;
1C351.a.50Porcine Teschovirus;
1C351.a.51Tick-borne encephalitis virus (Far Eastern subtype);
1C351.a.52Variola virus;
1C351.a.53Venezuelan equine encephalitis virus;
1C351.a.54Vesicular stomatitis virus;
1C351.a.55Western equine encephalitis virus;
1C351.a.56Yellow fever virus;
1C351.a.57Severe acute respiratory syndrome-related coronavirus (SARS-related coronavirus);
1C351.a.58Reconstructed 1918 influenza virus;
1C351.a.59Middle East respiratory syndrome-related coronavirus (MERS-related coronavirus);
1C351.bNot used;
1C351.cBacteria, whether natural, enhanced or modified, either in the form of "isolated live cultures" or as material including living material which has been deliberately inoculated or contaminated with such cultures, as follows:
1C351.c.1Bacillus anthracis;
1C351.c.2Brucella abortus;
1C351.c.3Brucella melitensis;
1C351.c.4Brucella suis;
1C351.c.5Burkholderia mallei (Pseudomonas mallei);
1C351.c.6Burkholderia pseudomallei (Pseudomonas pseudomallei);
1C351.c.7Chlamydia psittaci (Chlamydophila psittaci);
1C351.c.8Clostridium argentinense (formerly known as Clostridium botulinum Type G), botulinum neurotoxin producing strains;
1C351.c.9Clostridium baratii, botulinum neurotoxin producing strains;
1C351.c.10Clostridium botulinum;
1C351.c.11Clostridium butyricum, botulinum neurotoxin producing strains;
1C351.c.12Clostridium perfringens epsilon toxin producing types;
1C351.c.13Coxiella burnetii;
1C351.c.14Francisella tularensis;
1C351.c.15Mycoplasma capricolum subspecies capripneumoniae (strain F38);
1C351.c.16Mycoplasma mycoides subspecies mycoides SC (small colony);
1C351.c.17Rickettsia prowazekii;
1C351.c.18Salmonella enterica subspecies enterica serovar Typhi (Salmonella typhi);
1C351.c.19Shiga toxin producing Escherichia coli (STEC) of serogroups O26, O45, O103, O104, O111, O121, O145, O157, and other shiga toxin producing serogroups;
1C351.c.20Shigella dysenteriae;
1C351.c.21Vibrio cholerae;
1C351.c.22Yersinia pestis;
1C351.d"Toxins", as follows, and "sub-unit of toxins" thereof:
1C351.d.1Botulinum toxins;
1C351.d.2Clostridium perfringens alpha, beta 1, beta 2, epsilon and iota toxins;
1C351.d.3Conotoxins;
1C351.d.4Ricin;
1C351.d.5Saxitoxin;
1C351.d.6Shiga toxins (shiga-like toxins, verotoxins and verocytotoxins)
1C351.d.7Staphylococcus aureus enterotoxins, hemolysin alpha toxin, and toxic shock syndrome toxin (formerly known as Staphylococcus enterotoxin F);
1C351.d.8Tetrodotoxin;
1C351.d.9Not used;
1C351.d.10Microcystins (Cyanginosins);
1C351.d.11Aflatoxins;
1C351.d.12Abrin;
1C351.d.13Not used;
1C351.d.14Diacetoxyscirpenol;
1C351.d.15T-2 toxin;
1C351.d.16HT-2 toxin;
1C351.d.17Modeccin;
1C351.d.18Volkensin;
1C351.d.19Viscumin (Viscum Album Lectin 1);
1C351.d.20Brevetoxins;
1C351.d.21Gonyautoxins;
1C351.d.22Nodularins;
1C351.d.23Palytoxin;
1C351.d.24Neosaxitoxin (NEO).
1C351.eFungi, whether natural, enhanced or modified, either in the form of "isolated live cultures" or as material including living material which has been deliberately inoculated or contaminated with such cultures, as follows:
1C351.e.1Coccidioides immitis;
1C351.e.2Coccidioides posadasii.
Decontrol note
Les agents pathogènes ou toxines destinés à des usages médicaux, vétérinaires ou diagnostiques, sous forme de produits finis et conformes aux réglementations sanitaires, peuvent bénéficier d’exemptions sous conditions strictes.
General Technology Note (GTN)
The export of 'technology' which is 'required' for the 'development', 'production' or 'use' of items controlled in Categories 0 to 9 is controlled according to the provisions in each Category. 'Techno...
General Software Note (GSN)
The Lists do not control 'software' which is either: 1. Generally available to the public by being: a. Sold from stock at retail selling points, without restriction, by means of: (1) Over-the-counter ...
Category 1 - Special Materials and Related Equipment
This category covers special materials including toxic chemicals, biological agents, advanced materials (ceramics, composites), and their production equipment. Controlled items include: materials that...
Catch-All Clause - Article 4 of Regulation (EU) 2021/821
Article 4(1): An authorisation shall be required for the export of dual-use items not listed in Annex I if the exporter has been informed by the competent authority that the items in question are or m...
Cyber-Surveillance Catch-All - Article 5 of Regulation (EU) 2021/821
Article 5(1): An authorisation shall be required for the export of cyber-surveillance items not listed in Annex I if the exporter has been informed by the competent authority that the items in questio...